MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Deep Brain Stimulators in Parkinson`s subthalamic nucleus: A Study of Decade Follow-Up

    L. Neerati, V. Raju, G. Ramaraju (Hyderabad, India)

    Objective: To analyze the motoric and non-motoric symptoms of Parkinson`s following subthalamic-nuclei deep brain stimulations from a decade of follow-up study. Background: From the rudiment…
  • 2024 International Congress

    www.PregSpark.com, introducing the International PregnancieS and Parkinson’s Registry

    A. Oosterbaan, M. Kapelle, H. Bogers, L. Vos, B. Bloem, M. Meinders, B. Post (Nijmegen, Netherlands)

    Objective: To introduce the International PregnancieS and Parkinson’s Registry (www.PregSpark.com). Background: Pregnancy in Parkinson’s disease (PD) is rare, but with PD being the fastest growing…
  • 2024 International Congress

    Sexual Dimorphism in Clinical Subtypes, Biomarkers and Disease Progression of Parkinson’s Disease

    SM. Fereshtehnejad, H. Azizi, J. Lökk, Y. Zeighami (Toronto, Canada)

    Objective: To investigate differences in clinical subtypes, biomarkers, and course of progression in Parkinson’s disease (PD) between the two biological sexes. Background: PD is a…
  • 2024 International Congress

    Prodromal RBD and the risk of cognitive impairment in Parkinson’s disease.

    A. Martinez-Nunez, H. Hutchinson, V. Lavu, Q. Yuan, J. Dwarampudi, J. Wong (Gainesvile, USA)

    Objective: To identify the impact of prodromal RBD in the incidence of cognitive impairment in patients with early PD. Background: The association between sleep disorders…
  • 2024 International Congress

    Parkinson’s disease biomarkers in human olfactory cleft mucus

    J. Morley, N. Cohen, S. Koganti, S. Wood, H. Wang (Philadelphia, USA)

    Objective: To investigate and identify biomarkers for PD from human olfactory cleft mucus Background: Olfactory loss is an early symptom of PD, often preceding motor…
  • 2024 International Congress

    Nutritional Status Implication at 6 Months in Parkinson’s Disease: Follow-Up Results

    N. Ayo Mentxakatorre, B. Tijero, T. Fernandez-Valle, A. Ortiz-de-Echevarria, M. Acera Gil, I. Chavarri Rubio, C. Juanes Moreno, M. Ruiz-Lopez, JC. Gomez-Esteban, R. Del Pino (Barakaldo, Spain)

    Objective: To analyze the relationship between nutritional status and weight in 3 groups of patients with Parkinson's disease (PD) who are receiving different pharmacological therapies…
  • 2024 International Congress

    Prevalence of Helicobacter Pylori Infection Among Nepalese Parkinson’s Disease Patients and their Clinical Manifestations

    R. Ojha, B. Gajurel, R. Karn, R. Rajbhandari, R. Hamal, A. Jha, R. Pathak (Kathmandu, Nepal)

    Objective: To know the prevalence of Helicobacter Pylori infection among Nepalese Parkinson´s Disease patients and understand their clinical characteristics Background: Helicobacter pylori (HP) is prevalent…
  • 2024 International Congress

    Clinical correlates of apathy in Parkinson´s disease

    J. Arena, L. Fiorentini, C. Obarrio, M. Merello (Buenos Aires, Argentina)

    Objective: To investigate the demographic and clinical correlates of apathy in a group of patients from a Movement Disorders clinic in Latin America. Background: Apathy…
  • 2024 International Congress

    Interim Report of Quality of Life Outcomes After Deep Brain Stimulation for Parkinson’s Disease from a Large Global Real-World Study

    A. Gharabaghi, L. Lopez, A. Schnitzler, S. Chen, L. Himes, M. Frassica, D. Nanduri, S. Groppa (Tuebingen, Germany)

    Objective: To summarize quality of life outcomes after 2 years of deep brain stimulation (DBS) for Parkinson’s disease (PD). Background: DBS improves motor fluctuations associated…
  • 2024 International Congress

    Unveiling Parkinson’s Disease Risk Factors in the European Population-Based HeBA Cohort

    A. Garrido, C. Horlings, K. Rege, S. Schade, S. Ghosh, P. Mahlknecht, R. Rawal, T. Marques, D. Pilco, C. Gomes, C. Pauly, F. Farfan, D. Mcintyre, K. Seppi, MJ. Marti, C. Trenkwalder, W. Poewe, E. Tolosa, V. Satagopam, R. Krüger, B. Mollenhauer (Barcelona, Spain)

    Objective: Describe the frequency of Parkinson’s disease (PD) risk factors in a European population-based study and analyze the predictive value of online survey single questions…
  • « Previous Page
  • 1
  • …
  • 216
  • 217
  • 218
  • 219
  • 220
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley